- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05418192
Effects of Dosing and Environment on Gross Motor and Spasticity in Spastic Quadriplegic
Effects of Therapeutic Dosing Through Enriched Environment on Gross Motor Function and Spasticity in Spastic Quadriplegic Cerebral Palsy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 54000
- The University of Lahore Teaching Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Age Group between 7 months to 5 years.
- Spastic Quadriplegia
- Gross Motor Function Classification System (GMFCS) level IV and V
- Modified Ashworth Scale (MAS): level 2
- Both Gender
Exclusion Criteria:
History of fits
- Medications
- Dislocation and fracture
- Visual/Auditory Impairment
- Patients taking therapy from multiple places
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A
Intervention Given: Enriched Environment (age-appropriate) + NDT + Therapeutic Dosing
|
Enriched Environment (EE) consisted of motor and sensory enriched play environment to promote participant's self-generated movements, exploration and task success.
EE also included positioning in a graded manner.
Visual stimulus and level appropriate vestibular stimulus was also given.
Dosing of positioning and sensory inputs was done throughout the therapy.
Primary Intervention will be given for 20 to 25 minutes intermittently for period of 4-5 hours a day, 5 days a week for 24 weeks.
|
|
Other: Group B
Traditional Physical Therapy consisting of NDT
|
Participants of this group received traditional physical therapy based NDT.
No additional dosing guidance was given to this group.
No home program was specifically assigned to this group.
No specific environmental modifications were made for this group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gross Motor Function
Time Frame: 5 months
|
To check the improvement in gross motor function on Gross Motor Functional Measure scale of spastic quadriplegic cerebral palsy children. The scoring system of this scale is divided into five dimensions of gross motor function:(a) lying and rolling, (b) sitting, (c) crawling and kneeling, (d) standing, and (e) walking, running and jumping. The scoring is done on four points: 0=does not initiate
|
5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spasticity
Time Frame: 5 months
|
To check the improvement in spasticity on Modified Ashworth Scale scale in spastic quadriplegic cerebral palsy children.
The Modified Ashworth Scale is a 6-point scale.
Scores range from 0 to 4, where lower scores represent normal muscle tone and higher scores represent spasticity or increased resistance to passive movement.
|
5 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Safa Saleem, DPT, University of Lahore
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC-UOL-/74-03/2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spastic Cerebral Palsy
-
Suleyman Demirel UniversityCompletedCerebral Palsy | Hemiplegic Cerebral Palsy | Spastic Diplegia Cerebral PalsyTurkey (Türkiye)
-
Lahore University of Biological and Applied SciencesNot yet recruitingSpastic Diplegia Cerebral PalsyPakistan
-
Ankara City Hospital BilkentRecruitingCerebral Palsy (CP) | Cerebral Palsy, Spastic, Diplegic | Diplegic Cerebral Palsy With Spasticity | Transcranial Magnetic StimilationTurkey (Türkiye)
-
Beni-Suef UniversityNot yet recruitingUnilateral Spastic Cerebral Palsy
-
Cairo UniversityActive, not recruitingCerebral Palsy Spastic HemiplegicEgypt
-
Cairo UniversityCompletedCerebral Palsy Spastic HemiplegicEgypt
-
Gazi UniversityCompletedCerebral Palsy | Cerebral Palsy, Spastic | Cerebral Palsy Spastic Diplegia | Cerebral Palsy Quadriplegic | Cerebral Palsy, MonoplegicTurkey
-
Wroclaw University of Health and Sport SciencesNot yet recruitingSpastic Diplegia Cerebral Palsy | Spastic HemiplegiaPoland
-
TC Erciyes UniversityEnrolling by invitationCerebral Palsy (CP) | Spastic Diplegia Cerebral Palsy | Spastic Hemiplegic Cerebral PalsyTurkey
-
Istanbul University - CerrahpasaCompletedCerebral Palsy (CP) | Spastic Diplegia Cerebral Palsy | Spastic Hemiplegic Cerebral Palsy | Action Observation Therapy | Action Observation | Neurodevelopmental Disorder (Diagnosis)Turkey (Türkiye)
Clinical Trials on Enriched Environment
-
University of PadovaRecruitingStroke | Stroke, AcuteItaly
-
University of WashingtonCompletedDown Syndrome | Trisomy 21United States
-
Nanyang Technological UniversityRecruiting
-
Paul PoirierCompletedType 2 Diabetes | Glycemic ResponseCanada
-
University of Turin, ItalyCompletedGestational Diabetes Mellitus (GDM)Italy
-
Queen's University, BelfastCompletedSuboptimal Omega-3 IndexIreland, United Kingdom
-
Université Catholique de LouvainUniversity of Liege; University of MonsCompletedHealthy VolunteersBelgium
-
Hospital General Universitario Gregorio MarañonInstituto de Salud Carlos III; European Regional Development Fund; Maternal,...UnknownProtein-Energy MalnutritionSpain
-
Centre Hospitalier Universitaire DijonCompleted
-
Blekinge Institute of TechnologyKarolinska Institutet; Lund University; Göteborg University; Swedish Armed Forces...Not yet recruitingOxidative Stress | Hyperoxia | Oxygen Toxicity | Diving Medicine | Hydrogen-oxygen Gas | Healthy Subjects (HS) | Hyperbaric OxygenSweden